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Background: Ambulatory blood pressure monitoring is regarded as the gold standard for monitoring nocturnal
blood pressure (NBP) and is usually performed out of office. Currently, a novel method for monitoring NBP is
indispensible in the inpatient setting. The widely used manual BP monitoring procedure has the potential to
monitor NBP in the hospital setting. The feasibility and accuracy of manual sphygmomanometer to monitor NBP
has not been explored widely.
Methods: A cross-sectional study was conducted at the cardiology department of a university-affiliated hospital to
study patients with mild-to-moderate essential hypertension. One hundred and fifty-five patients were recruited to
compare BP derived from a manual device and ambulatory BP monitoring (ABPM). The manual BP measurement
was performed six times at 22:00, 02:00, 06:00, 10:00, 14:00 and 18:00 h. The measurements at 22:00, 02:00 and 06:00
h were defined as night-time and the others as daytime. ABPM was programmed to measure at 30-min intervals
between measurements.
Results: All-day, daytime and night-time BP did not differ significantly from 24-h ambulatory systolic BP [all-day
mean difference −0.52±4.67 mmHg, 95% confidence interval (CI) –1.26 to 0.22, P=0.168; daytime mean difference
0.24±5.45 mmHg, 95% CI −0.62 to 1.11, P=0.580; night-time mean difference 0.30±7.22 mmHg, 95% CI −0.84 to
1.45, P=0.601) rather than diastolic BP. There was a strong correlation between clinical and ambulatory BP for both
systolic and diastolic BP. On the basis of ABPM, 101 (65%) patients were classified as non-dippers, compared with
106 (68%) by manual sphygmomanometer (P<0.001).
Conclusions: Traditional manual sphygmomanometer provides similar daytime and night-time systolic BP
measurements in hospital. Moreover, the detection of non-dippers by manual methods is in good agreement with
24-h ABPM. Further studies are required to confirm the clinical relevance of these findings by comparing the
association of NBP in the hospital ward assessed by manual monitoring with preclinical organ damage and
cardiovascular and cerebrovascular outcomes.
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In recent decades, although out-of-office blood pressure
(BP) monitoring using ambulatory or home measurement
techniques has evolved rapidly [1-3], clinical BP measure-
ment has basically stayed the same [4-6]. Ambulatory BP
monitoring (ABPM) has been regarded as the standard* Correspondence: tanxuerui@vip.sina.com
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reproduction in any medium, provided the ormethod for diagnosis and management of hypertension
[7-9]. It is generally accepted that ABPM has better correl-
ation with end-organ damage and cardiovascular out-
comes compared with traditional office or clinic BP
measurement techniques [10-13].
However, in clinical practice, particularly in hospital
wards, BP mainly derived from traditional office blood
pressure measurement is one of the most important vital
signs [14]. In this context, comprehensive and accurate
measurement of clinical BP (CBP) level is of utmostThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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With regard to hypertension, appropriate assessment of
CBP level is the premise for risk stratification and ad-
equate therapeutic strategy. In clinical practice and re-
search, CBP is usually just performed in the daytime. In
the hospital ward, unless there are acute or severe condi-
tions, CBP is rarely performed at night-time. Information
about nocturnal BP (NBP) is extremely poor. Neverthe-
less, evidence has accumulated that NBP levels are more
favorable in predicting the mortality and morbidity related
to BP independently of daytime BP [17,18]. In contrast,
for the management of BP morning surge, NBP is also
indispensible [19]. Therefore, NBP should be taken ser-
iously in the hospital setting for every patient, especially
for those with abnormal BP.
Unfortunately, ABPM is regarded as the gold standard
for monitoring NBP and is usually performed out of office
[20]. Currently, a novel method for monitoring NBP is
indispensible in the hospital setting. Probably the widely
used manual BP monitoring has the potential to monitor
NBP in the inpatient setting.
To date, research exploring the feasibility and accuracy
of manual sphygmomanometer to monitor NBP has been
rare. The present study compared 24-h ABPM with trad-
itional manual techniques and used standard sphygmo-
manometer for the assessment of NBP and non-dippers
among patients with essential hypertension in a ward
setting.
Methods
Study design and population
This was a cross-sectional study in adults with essential
hypertension who were attending the cardiology depart-
ment of a university-affiliated hospital. The chief com-
plaint of all recruited patients was dizziness, and they
attended the hospital to establish the reasons for this diz-
ziness. None of the participants had any acute lesions that
influenced BP. Diagnosis and stratification of hypertension
were based on recent guidelines [21]. Newly diagnosed
patients or those on stable antihypertensive treatment for
at least 4 weeks were recruited. During the monitoring
period, the antihypertensive schedule had to remain the
same as before.
Exclusion criteria were severe cardiac, renal or other
systemic diseases, insomnia, and arrhythmia that inter-
fere with ABPM devices, as well as patients with morbid
obesity (body mass index >40 kg/m2). To ensure that
evaluation of NBP was as accurate as possible, shift
workers were also excluded. Secondary hypertension was
ruled out using the procedure suggested in the inter-
national literature [22]. The Ethics Committee of the
First Affiliated Hospital of Shantou University Medical
College approved the study. All of the participants gave
written informed consent.BP measurement and definitions
Daytime and night-time BP was measured by ABPM and
manual monitoring in random order within 2 days in
every patient. A standard sphygmomanometer (A&D UM-
101, A&D, Tokyo, Japan) was used to measure daytime
and night-time CBP. In the ward, all recruited patients
were instructed to go to bed around 22:00 h and arise
around 07:00 h. Six manual CBP measurements were
obtained from 22:00 h at 4-h intervals between measure-
ments. The actual times of CBP measurement were
around 22:00, 02:00, 06:00, 10:00, 14:00 and 18:00 h. All
the measurements were carried out by the same trained
examiner. Before the monitoring, all patients were in-
formed of the process and during the monitoring none of
the participants were deliberately awakened. The desk
lamp was switched on for the examiner to identify and
write down the readings. Triplicate BP monitoring with at
least 1 min between measurements using the same device
was performed at the daytime points (10:00, 14:00 and
18:00 h) after the patients had refrained from exercise, cof-
fee drinking, and smoking, and had relaxed for at least 5
min sitting in a quiet environment, as were the night-time
measurements (22:00, 02:00 and 06:00 h) in the supine
position. The inflatable cuff was always placed on the non-
dominant upper limb. The mean of the triplicate BP read-
ings was considered for analysis. Two inflatable bladder
sizes were available according to the individual’s arm cir-
cumference (22 × 12 and 30 × 14 cm).
Ambulatory BP was monitored using validated oscil-
lometric automatic-measuring device (A&D 2430) [23].
The ABPM device inflatable cuff was also placed on the
non-dominant upper limb. The monitors were prog-
rammed to measure BP at 30-min intervals for 24 h on
one of the two scheduled days. Patients were instructed
to follow similar activities and diets as for the manual
CBP measurement day, including no smoking or tea or
coffee consumption. In addition, patients were advised to
follow the guidelines of the monitors to avoid strenuous
physical activities and to remain with the forearm ex-
tended during each ABPM session. When the ambulatory
monitoring was completed, all the data were downloaded
though a computer link using special software provided
by A&D for analysis. Erroneous, valid and duplicate read-
ings were flagged by the software. The daytime was fixed
between 07:00 and 22:00 h because a fixed timetable for
sleeping and arising had been scheduled for patients in
the ward.
To guarantee that there was no consistent difference
of ≥10 mmHg in the measured BP between ABPM de-
vices and manual standard sphygmomanometer, before
and after each CBP measurement or ABPM session, the
accuracy of the monitors was assessed against a standard
mercury sphygmomanometer (three successive readings;
Y connector).
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CBP values with systolic BP (SBP) <90 mmHg or >200
mmHg and those with diastolic BP (DBP) <40 mmHg
or >110 mmHg were considered erroneous and were
discarded. If any of the aforementioned six consecutive BP
readings was invalidated or the sleeping duration was <
4 h, that patient’s data were excluded from the following
analysis. Three daytime (10:00, 14:00 and 18:00 h) and
three night-time (22:00, 02:00 and 06:00 h) CBP readings
were averaged to give a single daytime and night-time
CBP value per patient. Dipping pattern was defined as fol-
lows: dippers had a ≥10% but <20% fall in NBP; non-
dippers had an NBP fall <10% but >0%; extreme dippers
had an NBP fall ≥20%; and reverse dippers had an NBP in-
crease [24].
The 24-h ABPM data were divided into daytime (07:00–
22:00 h) and night-time (22:00–07:00 h) values. ABPM
measurements with three consecutive or a total of five
invalidated readings were regarded as erroneous and were
discarded, as were measurements with SBP <60 mmHg
or >250 mmHg and those with DBP <30 mm Hg or >
150 mmHg. Erroneous readings and duplicate readings
that the software flagged were also discarded. The means
of all valid daytime and night-time ABPM readings
were to give a single daytime and night-time ABPM value
per patient.
The data were stored and analyzed using the MS Excel
program. The statistical analysis was carried out using
SPSS for Windows release 13.0. The t test for paired sam-
ples was used to compare BP measurements in the same
individual and χ2 test was used to compare the categorical
variables. Pearson correlation coefficient and intraclass cor-
relation coefficient were used to estimate the association
between continuous variables. The κ statistic was used to
determine the level of agreement in diagnosis of non-
dippers measured by ambulatory blood pressure (ABP)
and CBP measurements. Two-tailed values of P<0.05 were
considered statistically significant.Results
Patient characteristics
A total of 169 patients were recruited and 14 were ex-
cluded because of inadequate ABPM data. Therefore,
155 patients were included in the final analysis (newly
diagnosed with essential hypertension 44.52%, men 51%,
smokers 23.9%, mean age 67±12 (SD) years, body mass
index 23.53±2.92 kg/m2, CBP 160.79±23.19/90.74±14.46
mmHg, SBP/DBP). Twenty-seven (17.4%) patients had
type 2 diabetes mellitus. Sixty-five participants (41.9%)
had a history of stroke and 32 (20.6%) had a previous
major cardiovascular disease. During the manual meas-
urement of NBP, about one half of participants (46%)
were awake.BP measurements
All-day CBP did not differ significantly from 24-hour ABP
for SBP [mean difference −0.52±4.67 mmHg, 95% confi-
dence interval (CI) –1.26 to 0.22, P=0.168; Figure 1). This
was also the case for daytime and night-time systolic CBP
as compared with ABP (daytime mean difference 0.24±
5.45 mmHg, 95% CI −0.62 to 1.11, P=0.580; night-time
mean difference 0.30±7.22 mmHg, 95% CI −0.84 to 1.45,
P=0.601; Figure 1). When compared with DBP, significant
differences were observed between manual sphygmoman-
ometer and ABPM for all-day (mean difference 1.49±3.70
mmHg, 95% CI 0.90–2.07, P<0.001), daytime (mean differ-
ence 1.48±4.69 mmHg, 95% CI 0.73–2.22, P<0.001), and
night-time (mean difference 2.41±4.51 mmHg, 95% CI
1.69–3.13, P<0.001) (Figure 1). There was a strong correl-
ation between CBP and ABP for both SBP and DBP
(Table 1).
Detection of non-dippers
On the basis of ABPM, 101 (65%) patients were classified
as non-dippers, as compared with 106 (68%) by manual
sphygmomanometer (P<0.001). When taking ABPM as
the reference standard to determine non-dippers, the
agreement was 82.58% as compared with CBP (κ 0.608,
P<0.001). Furthermore, when dividing the circadian rhy-
thm of BP into four groups, 61 participants were classified
as reverse-dippers (night-time BP higher than daytime) by
ABPM and 62 by CBP (diagnostic agreement 74.84%, κ
0.474, P<0.001). Five patients were defined as extreme-
dippers (nocturnal dip >20% for SBP/DBP) by ABPM
and five by CBP (diagnostic agreement 96.13%, κ 0.380,
P<0.001). When non-dippers were assessed separately for
SBP and DBP, the diagnostic agreements between ABP
and CBP are shown in Table 2.
Discussion
In this study, we compared manual sphygmomanometer
monitoring with 24-h ABPM in the inpatient setting, in
terms of daytime and night-time BP levels and the detec-
tion of BP circadian rhythm. The main conclusions were
that: (i) there were no differences between CBP and ABP
measurements taking during the daytime and night-time
for SBP rather than diastolic BP; and (ii) there was good
agreement between CBP and ABP in the detection of
non-dippers.
Since ABPM was firstly described >40 years ago, it has
been generally accepted that it can provide the following
three types of information: an estimate of mean BP level;
diurnal rhythm of BP; and BP variability [20], particularly
NBP. Currently, ABPM is considered as the gold standard
for NBP measurement [20,25]. However, this seemingly
perfect method for NBP measurement has its own limi-
tations, for example, disturbing sleep quality [26], high
cost, and inconvenience of performing multiple mea-
Figure 1 Comparison of clinical blood pressure measured by manual device and ambulatory blood pressure measurements (mean
difference ± SD; 95% confidence intervals in parentheses). CBP, clinical blood pressure; ABP, ambulatory blood pressure.
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urement methods has been investigated widely, especially
using home-monitoring devices. In 2001, a newly devel-
oped self-measurement BP device (Omron HEM 747-IC-
N, Omron Life Science, Tokyo, Japan) was investigated to
monitor NBP at 02:00 h [27]. The conclusion was that the
device could not provide ideal information on BP during
sleep [27]. Six years later, the aforementioned self-measure-
ment device was investigated to assess the reproducibility
in two different nights at a mean 5.9 days apart in 556 par-
ticipants [28]. This study concluded that the reproducibility
was poor, especially in individuals who experienced good
sleep quality in just one session [28].
A recent study in 40 healthy individuals has provided a
direct comparison between night-time home BP monitor-
ing and ABPM. No significant difference was found be-
tween the two methods for measurement of NBP [29].
Another more recent study [30] has compared ABP levels
with home BP values in 81 patients with hypertension.
NBP measurement was performed three times per night
on three nights within 2 weeks using automated devices
(Microlife WatchBPN; Microlife, Widnau, Switzerland). A
strong correlation was found between ABP levels and
home BP values [30]. This study concluded that home BP
monitoring may be a reliable alternative to ABP for the as-
sessment of NBP and the detection of non-dippers [30].Table 1 Comparison of the correlation in BP measured by
manual sphygmomanometer and ABPM
CBP-ABP r P ICC 95% IC P
All-day systolic 0.97 <0.001 0.944 0.924-0.959 <0.001
All-day diastolic 0.89 <0.001 0.878 0.836-0.969 <0.001
Daytime systolic 0.925 <0.001 0.922 0.895-0.943 <0.001
Daytime diastolic 0.831 <0.001 0.824 0.767-0.869 <0.001
Nighttime systolic 0.906 <0.001 0.903 0.869-0.928 <0.001
Nighttime diastolic 0.869 <0.001 0.857 0.809-0.894 <0.001
CBP: clinical blood pressure performed by manual device, ABP: ambulatory
blood pressure, r: correlation coefficients r, ICC: intraclass correlation
coefficients, CI: confidence interval.To the best of our knowledge, no studies have assessed
the potential of manual sphygmomanometer devices to
monitor NBP in an inpatient setting. Also, no studies have
directly compared NBP obtained by manual sphygmo-
manometer monitoring and ABPM. BP is one of the vital
signs and in hospital wards, it must be taken seriously.
Isolated nocturnal hypertension upon ambulatory meas-
urement as a novel clinical entity was first described by Li
et al. [31]. Isolated nocturnal hypertension predicts cardio-
vascular outcome in patients who are normotensive in the
office or with ambulatory daytime BP measurement [32].
Nonetheless, in clinical settings, unless there are acute or
severe conditions, NBP has not received enough attention.
In contrast, NBP measurement is also required to de-
termine the cause of the morning surge in BP. The
indispensible importance of NBP has been widely ac-
cepted. Therefore, we need to acknowledge the import-
ance of NBP not only out of office but also in clinical
settings, regardless of the condition of the patients.
In the present study, we compared CBP measured by
manual devices with automated ABPM. Regardless of the
all-day, daytime or night-time measurements, no signifi-
cant difference was found between the CBP and ABP for
SBP, despite a small number of readings being obtained
per night (n=3). The current study showed that NBP mon-
itoring performed by manual sphygmomanometer gave
similar values compared with ABPM. In contrast, strong
correlations were found between CBP and ABP. Despite
there being a small difference between ABP and CBP in
monitoring of NBP, the two methods appeared to beTable 2 Diagnostic agreement between CBP and ABP in
non-dippers
CBP-ABP Agreement (%) Kappa P
Systolic 84.52 0.596 P<0.001
Diastolic 83.23 0.521 P<0.001
Systolic or Diastolic 82.58 0.608 P<0.001
CBP: clinical blood pressure performed by manual device, ABP: ambulatory
blood pressure, the Kappa value was calculated in the condition of ABP as the
golden standard.
Xu et al. BMC Cardiovascular Disorders 2013, 13:37 Page 5 of 6
http://www.biomedcentral.com/1471-2261/13/37interchangeable in the detection of NBP in the clinical set-
ting. In our study, the two methods differed significantly
between CBP and ABP for DBP. The divergence of SBP
and DBP needs further study. Several reasons may explain
the divergence. First, manual monitoring or ABPM influ-
ence DBP more than SBP. Second, sleep quality may be af-
fected more by DBP than SBP. Finally, there is probably
no correlation between night-time DBP using the two
methods.
The most challenging finding of the present study was
that there was good agreement in the detection of non-
dippers, and moderate and fair agreement for reverse dip-
pers and extreme dippers, respectively. In 155 patients with
hypertension, >50% were found to be non-dippers using
both methods. Furthermore, about 60 patients were classi-
fied as reverse-dippers. This finding warned us that in the
clinical setting, nocturnal dipping of BP is much less fre-
quent, and even the NBP is much higher than the daytime
BP. It may have been that the patients were under stress,
and the percentage of non-dippers was high. Therefore, we
should not ignore the NBP in the hospital setting. It could
be that the ideal management of BP in the daytime results
in abnormal BP at night. The present study showed that
traditional widely used manual devices for monitoring
BP may give reliable NBP measurement compared with
ABPM. It should be noted, however, that there are no other
available data to define the non-dippers in clinical set-
tings, regardless of ABPM or other methods. More studies
should be performed to investigate the relationship be-
tween non-dippers measured by ABPM or CBP monitoring
in hospital wards and target organ damage or mortality.
Study limitation
The present study must be interpreted within the context
of its potential limitations. First, BP measurement was
only performed on 2 days, and one type of method was
just implemented once. Therefore, the reproducibility
could not be analyzed. Second, this study did not evaluate
the sleep quality associated with the two methods, which
may have seriously influenced NBP. Third, the study fixed
the daytime and night-time using an arbitrary range,
which may have affected the definition of non-dippers.
Conclusion
Our data suggest that traditional manual sphygmoman-
ometer provides similar daytime and night-time SBP in
the hospital ward. Moreover, the detection of non-dippers
by the manual methods is in good agreement with 24-h
ABPM, but moderate and fair agreement for reverse dip-
pers and extreme dippers, respectively. One challenge of
the study is that more than half of the patients in the ward
had high NBP. Further studies are required to confirm the
clinical relevance of these findings by comparing the asso-
ciation of NBP in the hospital ward assessed by manualsphygmomanometer monitoring and ABPM with preclin-
ical organ damage and cardiovascular and cerebrovascular
outcomes.
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